CAROLYN CATALANO: Open Payments
NPI 1912449331 · NEW BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,504 in 8 payments from 4 companies in 2025. Trend: 2023 $228 · 2024 $451 · 2025 $2,504
Consulting: $1,915Food & beverage: $589
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $1,155 |
| Intercept Pharmaceuticals, Inc. | 1 | $760 |
| Madrigal Pharmaceuticals | 5 | $565 |
| Mirum Pharmaceuticals, Inc. | 1 | $24 |
Products named: OCALIVA, REZDIFFRA, Livmarli.
Industry payments across NJ — which companies pay providers there.
